New FAQs address Stage 2 transitions of care measure

The Centers for Medicare & Medicaid Services and the Office of the National Coordinator of Health IT have jointly released two new FAQs that help explain requirements for the transitions of care measure for Meaningful Use Stage 2.

The measure's objective is:

The eligible professional (EP), eligible hospital or critical-access hospital (CAH) who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary care record for each transition of care or referral.

The FAQs focus on the certification criteria for this measure, as well as more detailed information about the objective. The questions are:

  • What certification approaches would satisfy the 2014 edition transitions of care certification criteria adopted at 45 CFR 170.314(b)(1) and (b)(2) as well as permit an eligible provider to have EHR technology that meets the Certified EHR Technology (CEHRT) definition? Please emphasize how the adopted transport standards fit in. Read the answer here.
  • For Meaningful Use Stage 2's transitions of care and referrals objective, in what ways can I meet the second measure that requires more than 10 percent of the summary care records I provide for transitions of care and referrals to be electronically transmitted? Read the answer here.
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup